Literature DB >> 8905081

The pathogenesis of tuberculosis.

G A Rook1, R Hernandez-Pando.   

Abstract

Tuberculosis patients relapse if treatment is not continued for 6 months, because chemotherapy fails to convert the patients' response from the necrotizing pattern characteristic of disease (Koch phenomenon) to the nonnecrotizing bactericidal function required for optimal immunity. We need to understand the nature of these two immunological states and how to convert one to the other. Studies in mice and humans implicate differences in cytokine profiles and in metabolism of adrenal steroids. Either enhanced susceptibility or protection can be evoked in mice with appropriate doses of a killed environmental saprophyte. This emphasizes the importance of shared epitopes and may explain the geographically variable efficacy of Mycobacterium bovis Bacillus Calmette Guérin vaccination. Unlike soluble antigens of M. tuberculosis itself, which tend to evoke necrosis, the shared mycobacterial epitopes evoke little skin-test reactivity in patients. Preparations of these epitopes show potential as immunotherapeutic agents to convert the response from necrotic to bactericidal mode.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905081     DOI: 10.1146/annurev.micro.50.1.259

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  45 in total

1.  A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis.

Authors:  R Hernández-Pando; H Orozco-Esteves; H A Maldonado; D Aguilar-León; M M Vilchis-Landeros; D A Mata-Espinosa; V Mendoza; F López-Casillas
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response.

Authors:  Jeffrey K Actor; Jessica Indrigo; Christopher M Beachdel; Margaret Olsen; Alice Wells; Robert L Hunter; Amitava Dasgupta
Journal:  Neuroimmunomodulation       Date:  2002 -2003       Impact factor: 2.492

3.  Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA.

Authors:  Jennifer L Taylor; Diane J Ordway; Jolynn Troudt; Mercedes Gonzalez-Juarrero; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Pathogenesis and immune response in tuberculous meningitis.

Authors:  Bini Estela Isabel; Hernández Pando Rogelio
Journal:  Malays J Med Sci       Date:  2014-01

5.  An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice.

Authors:  Vandana Kaul; Debapriya Bhattacharya; Yogesh Singh; Luc Van Kaer; Marc Peters-Golden; William R Bishai; Gobardhan Das
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

6.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; M De La Luz Streber; H Orozco; K Arriaga; L Pavon; S A Al-Nakhli; G A Rook
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

8.  Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection.

Authors:  Paolo Scarpellini; Silvana Tasca; Laura Galli; Alberto Beretta; Adriano Lazzarin; Claudio Fortis
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

9.  Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.

Authors:  Rogelio Hernández-Pando; Diana Aguilar; Hector Orozco; Yuriria Cortez; Laura Rosa Brunet; Graham A Rook
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

10.  Development and validation of an enzyme-linked immunosorbent assay for antibodies against Mycobacterium bovis in European wild boar.

Authors:  Olaia Aurtenetxe; Marta Barral; Joaquín Vicente; José de la Fuente; Christian Gortázar; Ramón A Juste
Journal:  BMC Vet Res       Date:  2008-11-01       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.